EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

From dosage alteration to amplification strategies: mechanistically defined alpha-synuclein mouse models for Parkinson’s disease therapy development

Silke Nuber iD, Saranna Fanning, Ulf Dettmer

Acta Neuropathologica · 30.10.2026 · 152 (1)

DOI: 10.1007/s00401-026-03112-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Neuropathologica, online erschienen am 30.10.2026. Verfasst von Silke Nuber und 2 weiteren Autor:innen. Beteiligte Einrichtung: Brigham and Women's Hospital, Harvard Medical School, ARCND, 60 Fenwood Rd, Boston, MA, 02115, USA. snuber@bwh.harvard.edu. Hauptthemen laut MEDLINE: alpha-Synuclein, Parkinson Disease, Disease Models, Animal. Die Arbeit nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke, Orchard Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A major challenge for identifying a disease-modifying cure for Parkinson’s disease (PD) is creating models resembling key features of the disease including resting tremor, bradykinesia, muscle rigidity and gait disturbances. In addition, PD patients often develop cognitive symptoms that are associated with pathology in neocortical areas. Initially, PD rodent models were generated primarily by chemical neurotoxins that induce an acute loss of dopaminergic neurons. Upon discovery of familial-PD-linked genetic mutations in the SNCA gene—encoding α-synuclein (αS)—mice carrying these mutations provided deeper insight into the pathologic role of this synaptic protein throughout the brain. αS transgenic mouse models stand out for their ability to develop intraneuronal lesions that are rich in αS phospho-serine 129, a histopathological signature of the human PD brain. Recent advances in αS protein biochemistry led to the generation of mice carrying strategic amplifications of familial-PD-linked αS mutants, resulting in more pronounced neurodegeneration and progressive phenotype development. Here we review advances of αS transgenic mouse model development with a focus on strategic mutations that may have greater potential for identifying underlying disease mechanisms than classical single-mutant and wild-type αS overexpressing mice. We also present how the mice are currently used in testing drug efficacy and target engagement for PD drug discovery and outline strategies for utilizing such mice in basic and translational research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinParkinson DiseaseDisease Models, AnimalAnimalsMice, TransgenicHumansMiceMutationBrain

Substanzen

alpha-Synuclein

Autor:innen und Institutionen

  • Brigham and Women's Hospital, Harvard Medical School, ARCND, 60 Fenwood Rd, Boston, MA, 02115, USA. snuber@bwh.harvard.edu.
  • Brigham and Women's Hospital, Harvard Medical School, ARCND, 60 Fenwood Rd, Boston, MA, 02115, USA.

ORCID-Profile: Silke Nuber

Förderung

  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke
  • Orchard Foundation
  • NINDS
  • Michael J. Fox Foundation for Parkinson's Research
  • Ellison Medical Foundation

Zitieren

APA

Nuber, S., Fanning, S., & Dettmer, U. (2026). From dosage alteration to amplification strategies: mechanistically defined alpha-synuclein mouse models for Parkinson’s disease therapy development. Acta Neuropathologica, 152(1). https://doi.org/10.1007/s00401-026-03112-4

Vancouver

Nuber S, Fanning S, Dettmer U. From dosage alteration to amplification strategies: mechanistically defined alpha-synuclein mouse models for Parkinson’s disease therapy development. Acta Neuropathologica. 2026;152(1). doi:10.1007/s00401-026-03112-4

BibTeX
@article{Nuber2026,
  author = {Nuber, Silke and Fanning, Saranna and Dettmer, Ulf},
  title = {From dosage alteration to amplification strategies: mechanistically defined alpha-synuclein mouse models for Parkinson’s disease therapy development},
  journal = {Acta Neuropathologica},
  year = {2026},
  volume = {152},
  number = {1},
  doi = {10.1007/s00401-026-03112-4}
}
Kostenlos starten →